Adaptogenics Health Corp., a science led company, focuses on identifying, acquiring, designing, and advancing proprietary peptide and small molecule programs. The company is focusing on evaluating opportunities in metabolic health, muscle preservation, mitochondrial biology and inflammation, including delivery technologies intended to enhance the performance of promising molecules. It is also involved in the nutraceutical operations evaluating GLP 1 companion products intended to address challenges associated with medical weight loss, including muscle loss, nutritional deficiencies, and reduced physical function. Adaptogenics Health Corp. was incorporated in 2021 and is headquartered in Vancouver, Canada.
Frequently asked questions
What sector does Adaptogenics Health Corp. (ADPT) operate in?
Adaptogenics Health Corp. belongs to the Consumer Staples sector and operates in the Packaged Foods industry.
What is Adaptogenics Health Corp. (ADPT) current stock price?
As of the latest data, Adaptogenics Health Corp. stock price is CA$0.29, with a previous close of CA$0.29.
What is Adaptogenics Health Corp. (ADPT) current market capitalization?
Adaptogenics Health Corp. market cap is approximately 1.19 million.
Does Adaptogenics Health Corp. (ADPT) pay dividends?
No. Adaptogenics Health Corp. does not pay a dividend.
What is Adaptogenics Health Corp. (ADPT) beta (volatility) score?
Adaptogenics Health Corp. has a beta of 0.451, indicating lower volatility than the overall market.